NASHUA, N.H., Oct. 14, 2025 /PRNewswire/ -- Conformal Medical, Inc., a medical device company developing next-generation technology for left atrial appendage occlusion (LAAO), today announced the ...
Conformal Medical has raised $32 million to support the development of its heart implant designed to reduce the lifetime risk of stroke among people with atrial fibrillation. The company said the ...
The MarketWatch News Department was not involved in the creation of this content. New partner reinforces confidence in the company's progress and future potential. NASHUA, N.H., Aug. 12, 2025 ...
New partner reinforces confidence in the company's progress and future potential. NASHUA, N.H., Aug. 12, 2025 /PRNewswire/ -- Conformal Medical, Inc., a medical device company developing ...
NASHUA, N.H., Jan. 16, 2025 /PRNewswire/ -- Conformal Medical, Inc., today announced that the early results of its GLACE Study will be presented during the Annual AF Symposium in Boston, MA on Friday, ...
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
Next-generation system to be highlighted during a technology innovation session and live case presentation by Professor Jens Erik Nielsen-Kudsk "With a single size, the CLAAS® AcuFORM™ implant can ...
Study will assess the Company's Next-Generation device under Intracardiac Echocardiography (ICE) imaging for Left Atrial Appendage Occlusion (LAAO) procedures. "Simplified sizing and ease of use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results